Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

LIMN

Liminatus Pharma, Inc.

USD

Set alert

Price alert · LIMN

All alert types
2.82 USD -0.08 -2.76%
As of Oct 30, 2026 Extended hours 2.83 +0.35%
Bid
2.75 × 1
Ask
2.83 × 1
2.75 Day range 3.00
2.82 52-week range 102.50
YTD
-90.75%
1 year
-96.00%
Open
2.98
Prev close
2.90
Mkt cap
3.79M
Vol
12.97K
Avg vol
223.18K
EPS
-23.50
P/E
0.00
Div yield
0.00%
More statistics
Low
2.75
High
3.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for LIMN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-28.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.4×
FY 2021: 38.5×FY 2022: -60.9×FY 2023: -33.4×FY 2024: -12.5×FY 2025: -1.4×
FY 2021 5y median -12.5× FY 2025
P/S 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -1.5×
FY 2021: 0.7×FY 2022: 133×FY 2023: -3.8×FY 2024: -2.3×FY 2025: -1.5×
FY 2021 5y median -1.5× FY 2025
P/FCF -1.5×
FY 2021: -142×FY 2022: -198×FY 2023: -12.0×FY 2024: -11.6×FY 2025: -1.5×
FY 2021 5y median -12.0× FY 2025
EV/EBITDA -1.6×
FY 2021: 39.5×FY 2022: -67.9×FY 2023: -51.2×FY 2024: -14.7×FY 2025: -1.6×
FY 2021 5y median -14.7× FY 2025
EV/Sales 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -68.9%
FY 2021: -0.7%FY 2022: -0.5%FY 2023: -8.3%FY 2024: -8.6%FY 2025: -68.9%
FY 2021 5y median -8.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 104.0%
FY 2021: 1.7%FY 2022: -226.2%FY 2023: 11.5%FY 2024: 18.3%FY 2025: 104.0%
FY 2021 5y median 11.5% FY 2025
ROIC 35.6%
FY 2021: -0.9%FY 2022: -9.5%FY 2023: -16.8%FY 2024: 398.0%FY 2025: 35.6%
FY 2021 5y median -0.9% FY 2025
ROA -1990.4%
FY 2021: 1.6%FY 2022: -18.9%FY 2023: -27.2%FY 2024: -102.7%FY 2025: -1990.4%
FY 2021 5y median -27.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 FY 2025
Operating Income -2.1%
FY 2021: 0.0%FY 2022: -6.9%FY 2023: 4.5%FY 2024: -12.4%FY 2025: -2.1%
FY 2021 FY 2025
EPS (diluted) -7.5%
FY 2021: 0.0%FY 2022: -163.3%FY 2023: -82.3%FY 2024: -166.7%FY 2025: -7.5%
FY 2021 FY 2025
Free Cash Flow -221.2%
FY 2021: 0.0%FY 2022: 28.5%FY 2023: -284.9%FY 2024: 7.1%FY 2025: -221.2%
FY 2021 FY 2025

Financial Health

Current Ratio 0.0×
FY 2021: 0.3×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2021 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2021: 0.3×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2021 5y median 0.1× FY 2025
Debt / Equity -0.1×
FY 2021: 0.0×FY 2022: 12.7×FY 2023: -1.5×FY 2024: -0.3×FY 2025: -0.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2021: -0.1×FY 2022: -4.2×FY 2023: -14.3×FY 2024: -1.6×FY 2025: -0.1×
FY 2021 5y median -1.6× FY 2025
Interest Coverage -13.7×
FY 2021: 0.0×FY 2022: -12.4×FY 2023: -14.8×FY 2024: -21.0×FY 2025: -13.7×
FY 2021 5y median -13.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31